MET and hepatocellular carcinoma: In a study conducted by Dang et al., it has been demonstrated that the enforced expression of miR-34a mimic enhanced the effect of cell proliferation inhibition and caspase activity induction of agents targeting c-Met in hepatocellular carcinoma [22].